• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    LifeMD Appoints Jessica Friedeman as Chief Marketing Officer to Support the Company's Rapid Expansion into Virtual Primary Care

    1/4/23 8:00:00 AM ET
    $LFMD
    Medical/Nursing Services
    Health Care
    Get the next $LFMD alert in real time by email

    NEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading direct-to-patient telehealth company, today announced the appointment of Jessica Friedeman as Chief Marketing Officer. Friedeman succeeds Stefan Galluppi, who continues as LifeMD's Chief Innovation Officer.

    Friedeman brings nearly twenty years' experience engaging and retaining patients, with a proven track record of increasing efficiency and revenue by executing go-to-market product strategy for forward-thinking, high growth companies. She offers specialized knowledge in customer relationship management, SaaS technology, and the application of actionable insights through data science. Friedeman has served as a leader in roles of increasing responsibility and impact through several acquisitions, including most recently as Chief Marketing Officer of Healthgrades, which was divested to Red Ventures in 2021, as well as Mercury Healthcare, which was acquired by WebMD in 2022.

    "We're thrilled to have Jessica with us as we advance our mission of using telehealth to provide patients a personalized and longitudinal relationship with a primary care physician. Her intimate knowledge of the patient journey, combined with her experience scaling B2B and B2C healthcare technology companies, will be integral in promoting the value of LifeMD to our current and future members," said Justin Schreiber, CEO and Chairman of LifeMD. "In the last year, over 177,000 patients have trusted LifeMD with their healthcare needs. This hire is the next step in our evolution as a leading provider of telehealth."

    "Having devoted my career to cultivating patient relationships, I'm honored to be joining a leader in telehealth who has demonstrated successes in providing seamless, end-to-end care," said Jessica Friedeman. "My focus will be on advancing LifeMD's deep expertise in performance marketing to create seamless patient journeys, build scalable technology that supports a best-in-class user experience, and engage partners who will further our patient-centric approach to virtual care."

    About LifeMD

    LifeMD is a 50-state direct-to-patient telehealth company with a portfolio of brands that offer virtual primary care, diagnostics, and specialized treatment for men's and women's health, allergy & asthma, and dermatological conditions. By leveraging its proprietary technology platform, 50-state affiliated medical group, and nationwide mail-order pharmacy network, LifeMD is increasing access to top-notch healthcare that is affordable to anyone. To learn more, go to LifeMD.com.

    Cautionary Note Regarding Forward Looking Statements

    This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: "believe," "expect," "anticipate," "project," "should," "plan," "will," "may," "intend," "estimate,"  "predict," "continue," and "potential," or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.

    Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, "Risk Factors" identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.

    Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation.

    Company Contact

    LifeMD, Inc.

    Marc Benathen, CFO

    [email protected]



    Primary Logo

    Get the next $LFMD alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $LFMD

    DatePrice TargetRatingAnalyst
    6/18/2025$15.00 → $18.00Buy
    BTIG Research
    12/10/2024$12.00Buy
    Lake Street
    12/4/2024$7.00Neutral
    Mizuho
    8/23/2024$11.00Buy
    B. Riley Securities
    6/5/2024$12.00Overweight
    KeyBanc Capital Markets
    11/30/2023$10.00Buy
    Craig Hallum
    7/21/2023$7.00Overweight
    Cantor Fitzgerald
    7/3/2023$9.00Buy
    H.C. Wainwright
    More analyst ratings

    $LFMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BTIG Research reiterated coverage on LifeMD with a new price target

      BTIG Research reiterated coverage of LifeMD with a rating of Buy and set a new price target of $18.00 from $15.00 previously

      6/18/25 10:55:14 AM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • Lake Street initiated coverage on LifeMD with a new price target

      Lake Street initiated coverage of LifeMD with a rating of Buy and set a new price target of $12.00

      12/10/24 8:29:49 AM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • Mizuho initiated coverage on LifeMD with a new price target

      Mizuho initiated coverage of LifeMD with a rating of Neutral and set a new price target of $7.00

      12/4/24 7:42:36 AM ET
      $LFMD
      Medical/Nursing Services
      Health Care

    $LFMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chairman and CEO Schreiber Justin sold $334,458 worth of shares (25,000 units at $13.38) (SEC Form 4)

      4 - LifeMD, Inc. (0000948320) (Issuer)

      7/3/25 3:53:16 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • Chief Financial Officer Benathen Marc David sold $1,682,440 worth of shares (125,000 units at $13.46), decreasing direct ownership by 27% to 339,554 units (SEC Form 4)

      4 - LifeMD, Inc. (0000948320) (Issuer)

      6/18/25 6:18:00 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • Chief Legal Officer & GC Yecies Eric Harold sold $183,750 worth of shares (15,000 units at $12.25) (SEC Form 4)

      4 - LifeMD, Inc. (0000948320) (Issuer)

      6/17/25 6:12:19 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care

    $LFMD
    SEC Filings

    See more
    • LifeMD Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - LifeMD, Inc. (0000948320) (Filer)

      6/16/25 4:43:54 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by LifeMD Inc.

      10-Q - LifeMD, Inc. (0000948320) (Filer)

      5/6/25 4:45:42 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • LifeMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - LifeMD, Inc. (0000948320) (Filer)

      5/6/25 4:10:25 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care

    $LFMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Innovation Officer Galluppi Stefan bought $14,790 worth of shares (3,000 units at $4.93), increasing direct ownership by 7% to 45,449 units (SEC Form 4)

      4 - LifeMD, Inc. (0000948320) (Issuer)

      9/12/24 2:10:03 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care

    $LFMD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

      NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ:LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on July 15, 2025, to holders of record at the close of business on July 3, 2025. About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men's and women's heal

      6/23/25 4:05:00 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • LifeMD to Participate in Two Investor Conferences During June

      NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of June: BTIG Obesity Health Forum, June 18. Management will participate in a virtual panel discussion titled "Direct to Consumer vs. Direct to Enterprise" at 2:00 p.m. Eastern time. Institutional investors can register for the conference by contacting their BTIG representative or by clicking here. Truist Securities Healthcare Disruptors & Digital Health Conference, June 24-25 at the Park Lane Hotel in New York City. Management will participate in a panel dis

      6/9/25 8:00:00 AM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®

      NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy® (semaglutide), which includes both the medication and access to LifeMD's virtual weight management program. As part of its collaboration with Novo Nordisk announced last month, LifeMD is offering Wegovy® at a discounted price of $199 for eligible patients through its recently completed integration with NovoCare® Pharmacy, with an additional $100 covering LifeMD's clinical care, onboarding, and ongoing support. The collaboration with Novo Nordisk strengthens LifeMD's a

      5/22/25 8:05:00 AM ET
      $LFMD
      Medical/Nursing Services
      Health Care

    $LFMD
    Leadership Updates

    Live Leadership Updates

    See more
    • LifeMD Set to Join the Russell 3000 Index

      NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, is set to join the broad-market Russell 3000® Index at the conclusion of the 2024 Russell U.S. Indexes annual reconstitution, effective at the open of U.S. equity markets on Monday, July 1st, according to a preliminary list of additions posted Friday, May 24th. The annual Russell U.S. Indexes reconstitution captures the 4,000 largest U.S. stocks as of Tuesday, April 30th, ranking them by total market capitalization. Membership in the U.S. all-cap Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Ind

      5/29/24 8:00:00 AM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • LifeMD Appoints Dr. Calum MacRae to its Board of Directors

      NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the appointment of Calum MacRae, M.D., Ph.D., a clinician, researcher and educator at Harvard Medical School, as an independent member of its Board of Directors. "We are delighted to welcome Dr. MacRae to the LifeMD Board of Directors. He brings deep experience in cardiology, internal medicine and clinical innovation, with a focus on disease management and the implementation of novel solutions to improve the delivery of virtual healthcare services," said Justin Schreiber, Chairman and Chief Executive Officer of LifeMD. "Aside from being a world-reno

      4/29/24 8:00:00 AM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • LifeMD Appoints William J. Febbo to its Board of Directors

      NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the appointment of William (Will) J. Febbo, Chief Executive Officer and Director of OptimizeRx Corporation (NASDAQ:OPRX) to its Board of Directors. OptimizeRx is a leading provider of digital point-of-care technology solutions that help patients start and stay on therapy. "We are extremely pleased to welcome Will to our Board. He brings to LifeMD a depth of experience in building and managing healthcare companies, and pioneering technology to improve the experience for healthcare providers and patients," said Justin Schreiber, Chairman and Chief Exec

      6/20/23 8:00:00 AM ET
      $LFMD
      $OPRX
      Medical/Nursing Services
      Health Care
      Business Services
      Consumer Discretionary

    $LFMD
    Financials

    Live finance-specific insights

    See more
    • LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

      NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ:LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on July 15, 2025, to holders of record at the close of business on July 3, 2025. About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men's and women's heal

      6/23/25 4:05:00 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • Medifast Announces First Quarter 2025 Financial Results

      Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2025. First Quarter 2025 Revenue of $115.7 million, with revenue per active earning coach of $4,556 Independent active earning OPTAVIA coaches of 25,400 Net loss of $0.8 million, which includes an unrealized gain on investment in LifeMD (NASDAQ:LFMD) common stock of $0.4 million (net of tax) Loss per share of $0.07 Cash, Cash Equivalents, and Investment Securities of $164.6 million with no debt "In today's health and wellness landscape, more people than ever are seeking guidance not just for we

      4/28/25 4:05:00 PM ET
      $LFMD
      $MED
      Medical/Nursing Services
      Health Care
      Packaged Foods
      Consumer Staples
    • LifeMD to Report First Quarter 2025 Financial Results on May 6

      NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on May 6, 2025 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Tuesday, May 6thTime:4:30 p.m. Eastern timeToll-Free Dial-In:800-225-9448International Dial-In:203-518-9708Conference ID:LIFEMDLive & Archived Webcast:Link   About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, a

      4/28/25 4:05:00 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care

    $LFMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by LifeMD Inc.

      SC 13G/A - LifeMD, Inc. (0000948320) (Subject)

      11/14/24 10:42:44 AM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by LifeMD Inc. (Amendment)

      SC 13G/A - LifeMD, Inc. (0000948320) (Subject)

      2/14/24 3:33:22 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by LifeMD Inc.

      SC 13G - LifeMD, Inc. (0000948320) (Subject)

      10/6/23 5:26:16 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care